Document is current
Any future updates will be listed below
-
Authors
Viapiana, Ombretta
Lee, Soohyun https://orcid.org/0000-0002-4798-2545
Yoon, SangWook https://orcid.org/0000-0003-4690-6054
Fautrel, Bruno https://orcid.org/0000-0001-8845-4274
-
Funding
Funding for this research was provided by:
Celltrion Healthcare
- License Information
-
More Information
Article History
Accepted: 21 November 2021
First Online: 13 January 2022
Declarations
:
: This article was supported by Celltrion Healthcare Co., Ltd. (Incheon, Republic of Korea).
: Ombretta Viapiana has received consulting fees or honorarium from Angelini, BMS, Fresenius Kabi, Galapagos, Gilead, Novartis and UCB, and lecture fees from AbbVie, Biogen and Eli Lilly. Soohyun Lee and SangWook Yoon are employees of Celltrion Healthcare Co., Ltd. Bruno Fautrel has received research grants from AbbVie, Lilly, MSD and Pfizer, and consultancy fees from AbbVie, Amgen, Biogen, BMS, Celltrion, Fresenius Kabi, Galapagos, Gilead, Janssen, Lilly, Medac, MSD, Mylan, NORDIC Pharma, Novartis, Pfizer, Roche, Sandoz, Sanofi-Genzyme, SOBI and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: All authors contributed to researching the content for this article, writing and/or critically reviewing the content, and provided final approval of the completed draft for submission.
